Anchora Medical Ltd.

Anchora Medical Ltd. is a medical device company specializing in innovative suturing solutions for endoscopic and open surgical procedures. The firm focuses on improving surgical techniques and outcomes with advanced technology. Founded in 2014, Anchora Medical Ltd.

is based in Yokneam Illit, Israel, where it designs and develops suturing devices for medical professionals. The firm had a recent funding round in February 2020, raising USD 4. 5 mn through a SERIES B financing, co-led by Hoya Corporation and Tal Capital Group LLC, with participation from Alon Medtech Ventures. The company has completed a total of 1 deal as of now.

Anchora specializes in the development of advanced suturing devices tailored for both endoscopic and open surgical applications. The company's flagship product, the Su2ura® Approximation Device, is a sterile, single-use device designed to streamline the suturing process by employing tiny stainless steel anchors threaded onto a surgical thread, enabling the placement of either interrupted or running stitches in soft tissue. This innovation addresses the technical complexities and time-consuming nature of minimally invasive suturing, ultimately enhancing surgical efficiency and patient outcomes. Anchora's products cater to a diverse customer base that includes hospitals, surgical centers, and healthcare professionals operating in regions such as Europe, Asia, and North America, where the demand for minimally invasive surgical solutions is steadily increasing.

Anchora's revenue structure revolves around direct sales to healthcare institutions and surgical centers, primarily through B2B transactions. The company engages clients through partnerships and distribution agreements, ensuring that its products, particularly the Su2ura® Approximation Device, are readily available in the market. The pricing model for these products is established based on the specific needs of healthcare providers and the volume of purchases, reflecting the advanced nature of the technology used in the devices. By fostering strong relationships with hospitals and surgeons, Anchora facilitates regular transactions, enabling healthcare professionals to access their innovative suturing solutions to improve surgical practices.

Anchora Medical Ltd. plans to utilize the USD 4. 5 mn raised in February 2020 to support the development of new products and expand its market reach. The company is focusing on designing additional surgical devices that will cater to a wider range of minimally invasive procedures, with expected launches in the upcoming years.

Additionally, Anchora is targeting expansion into key markets in Europe and Asia by the end of 2023, aiming to enhance the availability of its products in these regions and increase its overall market presence.